← Open Payments lookup

NEAL PATEL: Open Payments

NPI 1861020091 · LARGO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,691 in 149 payments from 20 companies in 2025. Trend: 2023 $1,201 · 2024 $808 · 2025 $2,691

Food & beverage: $2,691
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)21$368
ABBVIE INC.14$318
Teva Pharmaceuticals USA, Inc.32$314
Neurocrine BioSciences, Inc.13$300
Supernus Pharmaceuticals, Inc.14$212
Axsome Therapeutics, Inc.6$172
Alkermes, Inc.8$160
Noven Therapeutics, LLC8$157
Janssen Pharmaceuticals, Inc6$132
E.R. Squibb & Sons, L.L.C.5$125

Products named: CAPLYTA, VRAYLAR, INGREZZA, AUSTEDO XR, Qelbree, Auvelity, ARISTADA, Xelstrym.

Industry payments across FL — which companies pay providers there.